Schonfeld Strategic Advisors LLC

Position in JAZZ — Jazz Pharmaceuticals plc

CIK 1665241 NEW YORK, NY

Position in JAZZ

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$18,620,233

+$6,872,288 QoQ

Shares Held

77,272

+24.3% QoQ

Ownership

0.119%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

#96

of 640 holders

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. JAZZ ranks #3 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INBX	Inhibrx Biosciences, Inc.	697,586	$66,096,273
2	AGIO	Agios Pharmaceuticals, Inc.	520,083	$19,300,280
3	JAZZ	Jazz Pharmaceuticals plc This page	77,272	$18,620,233
4	VRDN	Viridian Therapeutics, Inc.\DE	793,508	$14,576,741
5	MBX	MBX Biosciences, Inc.	248,670	$13,726,584
6	XENE	Xenon Pharmaceuticals Inc.	227,330	$13,721,638
7	PTCT	Ptc Therapeutics, Inc.	147,425	$12,025,457
8	INSM	INSMED Inc	104,378	$11,128,782

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$18,620,233	77,272	+24.3%	Shares	Sole	2026-08-14
2026-03-31	$11,747,945	62,142	-55.4%	Shares	Sole	2026-05-15
2025-12-31	$23,666,890	139,217	-68.1%	Shares	Sole	2026-02-17
2025-09-30	$57,523,187	436,443	+592.1%	Shares	Sole	2025-11-14
2025-06-30	$6,691,927	63,060	+132.1%	Shares	Sole	2025-08-14
2025-03-31	$3,373,155	27,170	-7.3%	Shares	Sole	2025-05-15
2024-12-31	$3,610,388	29,317	-69.1%	Shares	Sole	2025-02-14
2024-09-30	$10,567,238	94,850	+2100.2%	Shares	Sole	2024-11-14
2023-12-31	$530,253	4,311	-79.6%	Shares	Sole	2024-02-14
2022-06-30	$3,291,654	21,099	+2.8%	Shares	Sole	2022-08-15
2021-03-31	$3,374,680	20,531	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.